<p><strong>Pediatric Use</strong>: The safety and effectiveness of Naftifine&nbsp;Cream have been established in the age group 12-17 with interdigital tinea pedis and tinea cruris.&nbsp;Safety and effectiveness in pediatric patients &lt;12 years of age have not been established.&nbsp;<br />
<br />
<strong>Geriatric Use</strong>: Clinical studies of Naftifine&nbsp;Cream did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.</p>